Cargando…

A comprehensive guide to toxicology in preclinical drug development /

A Comprehensive Guide to Toxicology in Preclinical Drug Development is designed for toxicologists who need a thorough understanding of the drug development process. This multi-contributed reference will provide a detailed picture of the complex and highly interrelated activities of preclinical toxic...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Faqi, Ali S.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London ; Waltham, MA : Academic Press, 2013.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ii 4500
001 SCIDIR_ocn815520350
003 OCoLC
005 20231117044751.0
006 m o d
007 cr cnu---unuuu
008 121031s2013 enka ob 001 0 eng d
010 |a  2013444252 
040 |a OPELS  |b eng  |e rda  |e pn  |c OPELS  |d CUX  |d UKMGB  |d OCLCQ  |d IDEBK  |d CHVBK  |d OCLCF  |d CDX  |d OCLCQ  |d USU  |d OCLCO  |d COCUF  |d AGLDB  |d E7B  |d YDXCP  |d N$T  |d EBLCP  |d DEBSZ  |d NRC  |d ICA  |d MERUC  |d FEM  |d LOA  |d K6U  |d STF  |d OCLCQ  |d OCLCO  |d OCLCQ  |d ZCU  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d D6H  |d OCLCO  |d VTS  |d OCLCO  |d ICG  |d BTN  |d AUW  |d MHW  |d INTCL  |d SNK  |d AU@  |d OCLCO  |d OCLCQ  |d WYU  |d OCLCO  |d OCLCA  |d VT2  |d OCLCO  |d LEAUB  |d OCLCO  |d DKC  |d OCLCO  |d OCLCQ  |d OCLCO  |d UX1  |d OCLCQ  |d OCLCA  |d OCLCO  |d OCL  |d HNC  |d OCLCQ 
016 7 |a 101600769  |2 DNLM 
016 7 |a 016209912  |2 Uk 
019 |a 818867493  |a 819506171  |a 820818932  |a 823134542  |a 960439333  |a 960738864  |a 968109050  |a 969021425  |a 972505722  |a 984782087  |a 1081256286  |a 1228554751 
020 |a 1283706504 
020 |a 9781283706506 
020 |a 9780123878168 
020 |a 0123878160 
020 |z 9780123878151  |q (p-ISBN) 
020 |z 0123878152  |q (p-ISBN) 
035 |a (OCoLC)815520350  |z (OCoLC)818867493  |z (OCoLC)819506171  |z (OCoLC)820818932  |z (OCoLC)823134542  |z (OCoLC)960439333  |z (OCoLC)960738864  |z (OCoLC)968109050  |z (OCoLC)969021425  |z (OCoLC)972505722  |z (OCoLC)984782087  |z (OCoLC)1081256286  |z (OCoLC)1228554751 
050 4 |a RA1238  |b .C66 2013 
060 4 |a 2013 A-659 
060 4 |a QV 771 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
082 0 4 |a 615.1/9  |2 23 
245 0 2 |a A comprehensive guide to toxicology in preclinical drug development /  |c edited by Ali S. Faqi. 
264 1 |a London ;  |a Waltham, MA :  |b Academic Press,  |c 2013. 
300 |a 1 online resource (xvi, 885 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |2 rda 
500 |a Title from pdf title page (viewed October 31, 2012). 
504 |a Includes bibliographical references and index. 
520 |a A Comprehensive Guide to Toxicology in Preclinical Drug Development is designed for toxicologists who need a thorough understanding of the drug development process. This multi-contributed reference will provide a detailed picture of the complex and highly interrelated activities of preclinical toxicology in both small molecules and biologics. Intended as a comprehensive resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations (CRO), this book will discuss discovery toxicology and the international guidelines for safety evaluation and present both traditional and nontraditional toxicology models. By incorporating the latest research in this area and featuring real-life examples and scenarios, this reference is a complete and practical guide to all aspects of preclinical drug testing. Chapters written by world-renowned contributors who are experts in their fields. Includes the latest research in preclinical drug testing and international guidelines. Covers preclinical toxicology in small molecules and biologics in one single source. Incorporates real-life case studies and examples and offers readers a practical resource that outlines day-to-day activities and experiences in preclinical toxicology. 
505 0 |a Front Cover; A Comprehensive Guide to Toxicology in Preclinical Drug Development; Copyright; Dedication; Contents; Foreword; Contributors; Chapter1 -- Introduction; Chapter2 -- ADME in Drug Discovery; INTRODUCTION; ADME; USE OF PRECLINICAL ADME DATA; TWO EVOLVING TECHNOLOGIES IMPACTING ADME IN DRUG DISCOVERY; References; Chapter3 -- Pharmacokinetics and Toxicokinetics; INTRODUCTION; DRUG ADMINISTRATION AND DELIVERY; INTRAVENOUS ADMINISTRATION; ABSORPTION AFTER EXTRAVASCULAR DOSING; CALCULATION OF EXPOSURE-BASED SAFETY MARGINS; PRACTICAL CONSIDERATIONS; CONCLUSIONS; References. 
505 8 |a Chapter4 -- Development of Preclinical Formulations for Toxicology StudiesINTRODUCTION; ANIMAL SPECIES, SAMPLING VOLUMES AND SAMPLING SITES; DOSING ROUTE; DOSING VOLUME; FORMULATION DEVELOPMENT; PHYSICO-CHEMICAL PROPERTY CHARACTERIZATION; SOLUBILITY ENHANCEMENT; SPECIAL DOSAGE FORMS; DECISION TREE; IN VITRO EVALUATION OF THE PERFORMANCE OF A TOXICOLOGICAL STUDY; CASE STUDY; CONCLUDING REMARKS; References; Chapter5 -- Acute, Sub-Acute, Sub-Chronic and Chronic General Toxicity Testing for Preclinical Drug Development; INTRODUCTION. 
505 8 |a REGULATORY CONSIDERATIONS FOR CONDUCTING PRECLINICAL TOXICOLOGY STUDIESGENERAL CONSIDERATIONS FOR THE CONDUCT OF PRECLINICAL TOXICOLOGY STUDIES; STUDY TYPES USED IN THE ASSESSMENT OF GENERAL TOXICOLOGY; SPECIAL CONSIDERATIONS FOR BIOPHARMACEUTICAL SAFETY EVALUATIONS; COMMON PROTOCOL COMPONENTS OF GENERAL TOXICITY ASSESSMENTS IN GLP STUDIES; FINAL THOUGHTS; References; Chapter6 -- Contemporary Practices in Core Safety Pharmacology Assessments; BACKGROUND AND OVERVIEW; SAFETY PHARMACOLOGY AS A REGULATORY SCIENCE; TEMPORAL APPLICATION OF CURRENT EXPERIMENTAL PARADIGMS. 
505 8 |a CARDIOVASCULAR SYSTEM AND MODELS OF SAFETY ASSESSMENTCARDIAC ION CHANNELS AND THE HERG ASSAY; IN VIVO CARDIOVASCULAR SAFETY STUDY; RESPIRATORY SYSTEM AND MODELS OF SAFETY ASSESSMENT; CENTRAL NERVOUS SYSTEM AND MODELS OF SAFETY ASSESSMENT; APPROACHES TO TIER I CNS SAFETY EVALUATION; EVALUATING CNS SAFETY; References; Chapter7 -- Genetic Toxicology Testing; INTRODUCTION; THE CONCEPT OF THRESHOLDS; GENETIC TOXICITY TESTING TO SUPPORT CLINICAL TRIALS; THE SENSITIVITY AND SPECIFICITY OF IN VITRO ASSAYS; IN VIVO CORE TESTS; OTHER IN VIVO TESTS FOR GENOTOXICITY. 
505 8 |a ADDITIONAL TESTS INDICATING GENOTOXICITYGENETOX TESTING STRATEGY: DISCOVERY THROUGH DEVELOPMENT; CONCLUDING REMARKS AND FUTURE DIRECTIONS; References; Chapter8 -- Clinical Pathology; INTRODUCTION; CORE CLINICAL PATHOLOGY TESTING; HEMATOLOGY; CYTOLOGICAL EVALUATION OF BONE MARROW; EMERGING BIOMARKERS AND APPLICATION WITHIN THE CLINICAL PATHOLOGY LABORATORY; CLINICAL PATHOLOGY INDICATORS OF TARGET ORGAN TOXICITY; INTERPRETATION OF CLINICAL PATHOLOGY DATA IN PRECLINICAL SAFETY STUDIES; References; Chapter9 -- Best Practice in Toxicological Pathology; INTRODUCTION. 
650 0 |a Drugs  |x Toxicology. 
650 0 |a Drug development. 
650 0 |a Clinical toxicology. 
650 0 |a Drugs  |x Side effects. 
650 1 2 |a Drug-Related Side Effects and Adverse Reactions  |0 (DNLM)D064420 
650 2 2 |a Drug Discovery  |0 (DNLM)D055808 
650 6 |a M�edicaments  |x Toxicologie.  |0 (CaQQLa)201-0007218 
650 6 |a M�edicaments  |x D�eveloppement.  |0 (CaQQLa)201-0306620 
650 6 |a Toxicologie clinique.  |0 (CaQQLa)201-0389746 
650 6 |a M�edicaments  |x Effets secondaires.  |0 (CaQQLa)201-0002241 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a Drugs  |x Side effects.  |2 fast  |0 (OCoLC)fst00898912 
650 7 |a Clinical toxicology.  |2 fast  |0 (OCoLC)fst00864428 
650 7 |a Drug development.  |2 fast  |0 (OCoLC)fst00898670 
650 7 |a Drugs  |x Toxicology.  |2 fast  |0 (OCoLC)fst00898958 
700 1 |a Faqi, Ali S. 
776 0 8 |i Print version:  |a Faqi, Ali S.  |t A Comprehensive Guide to Toxicology in Preclinical Drug Development.  |d Burlington : Elsevier Science, �2012  |z 9780123878151 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780123878151  |z Texto completo